| View |
|
BR-671
|
Human Normal Immunoglobulin(IGIV)
|
Gamma IV
|
50 mg/mL (2.5 g/50 mL)
|
Solution for IV Injection
|
Prescription Drug (RX)
|
50 mL USP Type I Glass Vial (Box of 1's)
|
Immuoglobulin
|
Bharat Serums and Vaccines Ltd.
|
India
|
|
BSV Bioscience Philippines, Inc.
|
Sandoval Distributors Inc.
|
Renewal
|
30 March 2021
|
10 February 2026
|
| View |
|
BR-673
|
Recombinant Human Thrombopoietin
|
Tpiao
|
15,000 IU/mL
|
Solution for Injection (S.C.)
|
Prescription Drug (Rx)
|
Single dose. Glass vial x 1mL (Box of 1's).
|
Colony-Stimulating Factors
|
Shenyang Sunshine Pharamceutical Co., Ltd.
|
China
|
N/A
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
Automatic Renewal
|
23 September 2022
|
23 September 2027
|
| View |
|
BR-674
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
NLT 106.0 CCID 50/1.5 mL
|
Oral Suspension
|
Prescription Drug (RX)
|
Pre-filled glass syringe x 1.5 mL (Box of l's, 10's and
50's)
|
-
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
Renewal
|
15 September 2022
|
13 August 2027
|
| View |
|
BR-676
|
Anti-Rabies Serum (Equine)
|
Equirab
|
200 IU/ mL (1,000 IU/ 5mL)
|
Solution for Injection (IM/SC)
|
Prescription Drug (Rx)
|
USP Type I Glass vial x 5mL (Box of 1's)
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
-
|
30 March 2021
|
06 March 2026
|
| View |
|
BR-680
|
HEPATITIS B VACCINE (RECOMBINANT DNA )
|
Unbranded
|
20mcg/mL
|
Suspension For Injection (IM)
|
Prescription Drug (RX)
|
Type I clear glass ampoule x 1mL (Box of 1's, 10's and 50's). Single dose.
|
VACCINE
|
Serum Institute of India Ltd.
|
India
|
|
Genpharm Inc.
|
Genpharm Inc.
|
Renewal
|
01 March 2024
|
01 June 2029
|
| View |
BR-689_PI_01.pdf
|
BR-689
|
Tocilizumab
|
Actemra
|
400 mg/ 20 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
10 April 2023
|
20 March 2028
|
| View |
BR-690_PI_01.pdf
|
BR-690
|
Tocilizumab
|
Actemra
|
80 mg/ 4 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
14 April 2023
|
20 March 2028
|
| View |
BR-691_PI_01.pdf
|
BR-691
|
Tocilizumab
|
Actemra
|
200 mg / 10 mL
|
Concentrate For Solution For I.V. Infusion
|
Prescription Drug (RX)
|
20 mL colorless Type I glass vial per box
|
Interleukin Inhibitor
|
Chugai Pharma Manufacturing Co., Ltd.
|
Japan
|
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
09 April 2023
|
20 March 2028
|
| View |
|
BR-698
|
Filgrastim
|
Recombicyte
|
300mg/0.9mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
0.9 m L Pre-filled Syringe (Box of 1's)
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
N/A
|
Global Pharmatrade
|
Global Pharmatrade
|
Renewal
|
27 April 2021
|
01 July 2026
|
| View |
BR-701_PI_01.pdf
|
BR-701
|
Epoetin Alfa
|
Eprex
|
4000 IU/0.4 mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
0.4 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l's)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|
| View |
BR-702_PI_01.pdf
|
BR-702
|
Epoetin Alfa
|
Eprex
|
10000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l’s)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|
| View |
BR-704_PI_01.pdf
|
BR-704
|
Epoetin Alfa
|
Eprex
|
40000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Solution in a Type I pre-filled glass syringe
fitted with PROTECSTM needle guard (Box of l’s)
|
-
|
Cilag AG
|
Switzerland
|
N/A
|
Johnson & Johnson (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
04 February 2022
|
29 July 2026
|
| View |
|
BR-713
|
Recombinant Human Erythropoietin Alfa
|
Efotin
|
4000 IU/0.8mL
|
Solution For IV Injection
|
Prescription Drug (RX)
|
Type I Glass Pre-filled Syringe (Net content: 0.8 mL) (Box of 1's)
|
-
|
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
|
China
|
N/A
|
Global Pharmatrade
|
Global Pharmatrade
|
-
|
21 April 2021
|
11 February 2026
|
| View |
|
BR-733
|
Human Normal Immunoglobulin (IVIg)
|
Gamunex-C
|
10% (100 mg/mL)
|
Solution for Infusion (IV/SC)
|
Prescription Drug (RX)
|
Clear, colorless Type I glass vial x 10 mL, 25 mL, 50
mL and 100 mL (Box of 1's)
|
-
|
Grifols Therapeutics LLC
|
U.S.A
|
N/A
|
GB Distributors Inc.
|
GB Distributors Inc.
|
-
|
27 April 2022
|
26 May 2027
|
| View |
|
BR-737
|
Diphtheria and Tetanus Vaccine (Adsorbed)
|
SII TD-VAC
|
Formulation: Each dose (0.5 mL) contains: Diphtheria Toxoid.........<5 Lf 2 2 IU) Tetanus Toxoid................<5 Lf( 40 IU) Adsorbed on Aluminum Phosphate, Al3+.....................< 1.25 mg
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
Single dose. Ampoule x 0.5 mL (Box of ’s and 50's).
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
N/A
|
Medical Vaccines Online Deliveries
|
Medical Vaccines Online Deliveries
|
Renewal
|
02 June 2022
|
27 April 2027
|
| View |
|
BR-740
|
Somatropin
|
Genheal
|
4 IU (equivalent to 1.6 mg)
|
Lyophilized Powder for
Injection (IM/SC)
|
Prescription Drug (RX)
|
2 mL Type I Glass Vial (Box of 1’s)
|
-
|
Shanghai United Cell Biotechnology Co., Ltd.
|
China
|
N/A
|
Unilab, Inc.
|
Unilab, Inc.
|
Renewal (Revalidation)
|
17 October 2022
|
26 July 2025
|
| View |
|
BR-744
|
Recombinant Hepatitis B Vaccine
|
Engerix B
|
20 mcg/mL
|
Suspension for Injection (IM)-Thiomersal Free
|
Prescription Drug (Rx)
|
1 mL Pre-filled Syringe + 1 Sterile needle [25G x 1"] (Box of 1's)
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
Initial (Variation)
|
28 June 2024
|
28 June 2029
|
| View |
|
BR-745
|
Recombinant Hepatitis B Vaccine
|
Engerix B Junior
|
10 mcg/0.5 mL
|
Suspension for Injection
|
Prescription Drug (RX)
|
1.25 mL mL (0.5 mL-net content) Type I pre-filled glass syringe with bromobutyl rubber plunger stopper, FM30 Styrene butadiene rubber tip cap, and Luer lock adaptor (Box of 1's).
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Initial (Variation)
|
30 October 2024
|
30 October 2029
|
| View |
|
BR-746
|
Filgastrim
|
Leucogen
|
300mcg/mL
|
Solution For Iv/Sc Injection
|
Prescription Drug (RX)
|
1 ml Type I Clear and Colorless Glass Vial (Box of 10's)
|
-
|
Center for Molecular Immunology (CIM)
|
Cuba
|
Innogene Kalbiotech Pte. Ltd.
|
Globo Asiatico Enterprises, Inc.
|
Globo Asiatico Enterprises, Inc.
|
-
|
17 February 2021
|
04 August 2025
|
| View |
|
BR-747
|
Human Albumin
|
Albiomin
|
20% (200 g/L)
|
Solution for Injection for IV Infusion
|
Prescription Drug (RX)
|
50 mL and 100 mL Clear, Colorless Type II (Ph. Eur)
Soda-Lime Silica Glass Vials with Bromobutyl Rubber Stopper (Type I Ph. Eur) (Box of 1's)
|
-
|
Biotest Pharma GmbH
|
Germany
|
|
EC Zuric Biotherapies, Inc.
|
EC Zuric Biotherapies, Inc.
|
-
|
19 February 2021
|
07 September 2025
|